Skip to content
Open access

Lipidomes of placenta-derived extracellular vesicles reveal disrupted metabolic adaptation in type 1 diabetes.

Oct 2026 · Journal of Clinical Endocrinology and Metabolism · 0 citations
Medicine

TL;DR

Circulating P-sEV lipid profiles reflect disrupted placental metabolic adaptation in T1D pregnancy and are associated with fetal hyperinsulinemia at birth, supporting their potential for minimally invasive assessment of placental function.

Abstract

Context

Placental metabolic adaptation is dynamically orchestrated across gestation to support fetal development, yet how this process is disrupted in type 1 diabetes (T1D) and contributes to altered fetal metabolic outcomes remains unclear. Small extracellular vesicles (sEVs) may provide a minimally invasive window into placental metabolic state during pregnancy.

Objective

To determine whether lipidomic profiling of placental sEVs (P-sEVs) in maternal circulation captures dynamic placental metabolic adaptation and its dysregulation in T1D pregnancy.

Design

AND

Setting

Prospective longitudinal cohort study conducted within the Ontario Birth Study and the Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT) study.

Participants

Maternal plasma samples were collected across gestation (10-14, 24-32, and 34-40 weeks of gestation) from 200 normoglycemic pregnancies and 151 pregnancies from individuals with preexisting T1D.

Methods

Placental sEVs were isolated and characterized, and lipid composition was quantified using shotgun mass spectrometry-based lipidomics. Multivariate and machine learning approaches were applied to define gestational lipid trajectories and assess associations with fetal metabolic outcomes. MAIN OUTCOME MEASURES Gestational lipid trajectories in P-sEVs from normoglycemic and T1D, and their association with maternal and fetal risk factors and clinical outcomes.

Results

Placental sEVs from T1D pregnancies exhibited increased vesicle size and reduced abundance. Lipidomic profiling revealed divergence in the magnitude, direction, and timing of gestational lipid trajectories compared with controls. Lipid species involved in membrane remodeling and bioactive signaling distinguished pregnancies with high vs low cord blood C-peptide, a marker of fetal endogenous insulin secretion, with strong discrimination (area under the characteristic curve = 0.85).

Conclusion

Circulating P-sEV lipid profiles reflect disrupted placental metabolic adaptation in T1D pregnancy and are associated with fetal hyperinsulinemia at birth, supporting their potential for minimally invasive assessment of placental function.

Read PDF

Similar papers

Open access Oct 2026

Proteomic Profiling of Xenobiotic and Nutrient Transporters in Human Placenta of Different Gestational Ages

The placenta serves a critical role in nutrient uptake and waste elimination for the developing fetus. The placenta is also responsible for the uptake and/or exchange of xenobiotics, including medications, between the maternal and fetal bloodstreams. An estimated 40–80% of women take medications or drugs during pregnan...

Eric M. Weaver, A. Topletz-Erickson, Edward J. Kelly et al. · 0 citations
Open access Oct 2026

Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes

Purpose This study characterized metabolomic profiles of maternal adipose tissue, placenta, and cord blood in pre-pregnancy obesity and explored links to adverse pregnancy outcomes (APOs). Methods From a prospective cohort (Oct 2024–Oct 2025, n = 1,335), 25 obese (pre-pregnancy BMI ≥ 28 kg/m2) and 25 control women unde...

Ke-Hang Ye, Y. Liu, J. Zou et al. · 0 citations
Sep 2026

Integrated proteomic characterization of maternal blood, umbilical cord blood and placental tissue in gestational diabetes mellitus.

Gestational diabetes mellitus (GDM) is associated with adverse maternal and neonatal outcomes, but molecular alterations across the maternal-placental-fetal interface remain incompletely defined. We applied data-independent acquisition mass spectrometry to matched maternal blood (MB), umbilical cord blood (UCB) and pla...

Xiu-Bin Jia, Qi Wu, Yao-Han Li et al. · 0 citations
Open access Oct 2026

Multi-omic profiling defines subtype-specific extracellular vesicle signatures in early human pregnancy.

Early human pregnancy (11-15 weeks) is a critical period when placental dysfunction begins but remains clinically undetectable, preventing early intervention for pregnancy complications. This highlights a pressing need for circulating biomarkers that can signal the onset of a complication. Circulating extracellular ves...

Kobe A. Abney, Taylor Hollingsworth, Alexandra Schneider et al. · 0 citations
Review Open access Oct 2026

Placental programming of metabolic diseases: molecular pathways from maternal pregnancy complications to offspring metabolic risk

The placenta is increasingly recognized as a dynamic regulatory organ that translates both maternal and paternal physiological and pathological states into developmental signals into developmental signals shaping offspring health across the lifespan. In the context of maternal metabolic and obstetric complications,...

Duo Zhou · 0 citations
Open access Oct 2026

Disentangling maternal pregnancy and fetal-specific plasma signatures through integrated proteomics and site-specific N-glycoproteomics

It is found that the fetus and mother have distinct proteomes, N-glycoproteoforms and alternative complement regulation, and that pregnancy in women led to specific N-glycosylation changes on a select set of primarily HDL-associated and acute-phase proteins.

Shelley Jager, S. K. Nteak, Grigory Reznikov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.